Early Phase 1 Lip Clinical Trials
6 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–6 of 6 trials
Recruiting
Early Phase 1
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
Synovial SarcomaMyxoid LiposarcomaRound Cell Liposarcoma
Northwestern University8 enrolled1 locationNCT07261657
Recruiting
Early Phase 1
Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
ObesityDyslipidemias
University of Connecticut130 enrolled1 locationNCT05700916
Recruiting
Early Phase 1
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
Metastatic Colorectal Cancer (CRC)Oxaliplatin Induced Peripheral Neuropathy in Cancer PatientsPeripheral Neuropathy Due to Chemotherapy
Fox Chase Cancer Center30 enrolled1 locationNCT07167446
Recruiting
Early Phase 1
Differential Thrombogenesis by EPA and DHA Mediated by HDL
HypertriglyceridemiaLipid Metabolism Disorders
The Miriam Hospital80 enrolled1 locationNCT06494488
Recruiting
Early Phase 1
Akkermansia Muciniphilia and Metabolic Side Effects of ADT
Prostate CancerObesityMetabolic Syndrome+4 more
Western University30 enrolled1 locationNCT05802121
Withdrawn
Early Phase 1
An evaluative study to assess the safety of Nanocelle (Trademark) Atorvastatin Formulation Administered Oro-buccally (by mouth spray) in Healthy Adult Volunteers.
Hyperlipidaemia
Medlab Pty Ltd12 enrolled1 locationACTRN12615001285549